Patients in Vietnam and other locations with central nervous system infections may well be suffering from the effects of a newly discovered virus, according to a study to be published in mBio®, the online open-access journal of the American Society for Microbiology. Researchers have detected the virus in spinal fluid from 4 percent of 642 patients with central nervous system infections of unknown cause, and in an average of 58 percent of fecal samples from pigs and poultry, suggesting animals may serve as reservoirs for transmission to humans. The virus, called CyCV-VN, belongs to the Cyclovirus genus, a group that has never before been implicated in human or animal disease.
"The detection of CyCV-VN in a usually sterile material like cerebrospinal fluid is remarkable and may point to a pathogenic role of this virus as a single or a co-infecting pathogen," says corresponding author Tan Le Van of the Oxford University Clinical Research Unit in Ho Chi Minh City, Vietnam. The results in this study, Van cautions, do not provide absolute proof of disease causation, and further work is needed to see whether the virus poses a threat to human and animal health.
Acute central nervous system infections are responsible for illnesses and deaths around the world, but they are a particular problem in tropical regions. These infections can be caused by any of a number of bacterial, parasitic, fungal or viral pathogens, but the majority of cases go undiagnosed despite extensive efforts to identify a cause. "One of our particular interests is to improve patient diagnosis," says Van. Proper diagnosis "is essential to improve clinical management and prevention of these devastating diseases, he continues.
Inspired by the high incidence of acute central nervous system infections in Vietnam, Van and his colleagues set out to identify previously uncharacterized viruses in undiagnosed patients. Using fluid samples from more than 1,700 patients with suspected central nervous system infections or suspected viral encephalitis, the researchers generated 161,000 DNA sequence reads for further analysis.
Among these thousands of sequences, the researchers identified a sequence from a member of the Cyclovirus genus that was present in two patients, one adult and one child, both with acute central nervous system infections of unknown cause. Follow-up work with a technique called inverse PCR used that short sequence to determine the entire genome sequence of the virus present in one of the samples. CyCV-VN is a unique new species of Cyclovirus, a group that includes no known pathogens.
With the full genome in hand, the researchers went back to 642 samples from patients with suspected acute central nervous system infections and were able to detect the virus in samples from 26 patients (4 percent). The virus was not detected at all in samples from patients with non-infectious conditions of the central nervous system, like multiple sclerosis, a fact that argues that the virus could well be a human pathogen.
The virus was also detected in samples from farm animals in the province where the index patient lived: between 42 percent and 100 percent of fecal samples from pigs, ducks, and chickens in that region harbored viruses that are extremely closely related to CyCV-VN. This raises the possibility - but not certainty - say the authors, that livestock could represent a source for human infection with the virus.
Van also cautions that it is too soon to point an accusing finger at CyCV-VN. "Detection of a virus in human samples alone is insufficient to provide a direct link with an ongoing infection," he says. "Addressing the question of causation requires extensive effort."
Van says they are currently trying to isolate the virus in cell culture and develop a serological assay. If they are able to identify an antibody response to the virus in patient samples, he says, they would be one step closer to linking the virus to disease. They are also working with research groups outside Vietnam to explore the geographic spread of the virus.
mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://mbio.asm.org.
The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM's mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.